Pharmacogenomics Testing Market - Top Companies and Manufacturers

  • Report ID: 5787
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Pharmacogenomics Testing Landscape

    • PerkinElmer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Dynamic DNA Laboratories
    • Sonic Healthcare
    • QIAGEN
    • Eurofins Scientific
    • 23andMe, Inc
    • OneOme
    • Pacific Biosciences of California, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • PacBio and Twist Bioscience Corporation declared the availability of an initial portfolio of off-the-shelf long-read gene panels in October 2022. To effectively and efficiently capture the target areas, these fixed panels of Twist Alliance are constructed. Moreover, customers will be able to create a panel of their designs which is fully adaptable and scalable for sequencing using the PacBio HiFI read.
  • In May 2023, PerkinElmer Inc. announced the launch of Revvity, Inc. as a provider of science based solutions that use advances in diagnostics and life sciences to improve people's lives around the world. Already, the commerce was associated to PerkinElmer, Inc. Clients of Revvity come from different businesses, counting pharma and biotech, symptomatic labs, the scholarly community, and administrative organizations.  Reagents, consumables, assays, instruments and software are available from Revvity.

Author Credits:  Radhika Pawar


  • Report ID: 5787
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pharmacogenomics testing is assessed at USD 13.97 billion.

The pharmacogenomics testing market size was valued at USD 13.06 billion in 2024 and is expected to reach USD 38.63 billion by 2037, expanding at around 8.7% CAGR during the forecast period i.e., between 2025-2037. The growing demand for personalized medicines and growing integration EHR will drive the market growth.

North America industry is poised to hold largest revenue share of 35% by 2037, due to rising substantial healthcare expenditure in the region.

The major players in the market are of Thermo Fisher Scientific Inc., Dynamic DNA Laboratories, Sonic Healthcare, QIAGEN, Eurofins Scientific, 23andMe, Inc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample